In 2023, childhood hypoglycaemia remains a major public health problem and significant
risk factor for consequent adverse neurodevelopment. Irrespective of the underlying cause …

Hypoglycaemia in children is a major risk factor for adverse neurodevelopment with rates as
high as 50% in hyperinsulinaemic hypoglycaemia (HH). A key part of management relies …

The National Institute for Clinical Excellence (NICE) now recommends that continuous
glucose monitoring (CGM) be offered to adults and children with diabetes who are at risk …

Aim The aim of this meta-analysis was to evaluate the impact of continuous glucose
monitoring (CGM) systems on short-and long-term glycemic control in children and …

Severe hypoglycemia is defined as a condition with serious cognitive dysfunction, such as a
convulsion and coma, requiring external help from other persons. This condition is still lethal …

Background and objectives Continuous glucose monitoring (CGM) could be a valuable
instrument for measurement of glucose concentration in preterm neonate. We undertook a …

Abstract Purpose of Review Continuous glucose monitoring (CGM) technology has long
been accepted as a tool for managing glycemia in type 1 diabetes (T1D) and is receiving …

Context Continuous glucose monitoring (CGM) is increasingly being used both for day-to-
day management in patients with diabetes and in clinical research. While data on glycemic …

Background: The glycemic patterns of children less than 7 years with type 1 diabetes have
not been well studied using continuous glucose monitoring. Our goal was to assess the …

Although recent clinical trials of continuous glucose monitoring (CGM) use have shown
positive glycemic benefit (1, 2), outcomes outside the research setting may differ and real …